Texas A&M Researcher Helps Develop First Treatment For Rare Type Of Refractory Epilepsy

Samba Reddy has spent decades working to bring ganaxolone and neurosteroid replacement therapy to patients.

Related Keywords

India ,United States ,Texas ,Michael Rogawski ,Us Department Of Defense ,Panjab University In Chandigarh ,Texasam University ,Biomedical Advanced Research ,Us National Institutes Of Health ,Drug Administration ,Development Authority ,Texasam University School Of Medicine ,Department Of Neuroscience ,Kakatiya University In Warangal ,Texasam School Of Medicine ,Carolina State University ,Institute Of Pharmacology ,National Institute Of Neurological Disorders ,Kakatiya University ,Panjab University ,Regents Professor ,Experimental Therapeutics ,Engineering Medicine ,Biomedical Engineering ,Veterinary Integrative Biosciences ,North Carolina State ,National Institute ,Neurological Disorders ,